Regulation of human EGF receptor by lipids

The human epidermal growth factor receptor (EGFR) is a key representative of tyrosine kinase receptors, ubiquitous actors in cell signaling, proliferation, differentiation, and migration. Although the receptor is well-studied, a central issue remains: How does the compositional diversity and functional diversity of the surrounding membrane modulate receptor function? Reconstituting human EGFR into proteoliposomes of well-defined and controlled lipid compositions represents a minimal synthetic approach to systematically address this question. We show that lipid composition has little effect on ligand-binding properties of the EGFR but rather exerts a profound regulatory effect on kinase domain activation. Here, the ganglioside GM3 but not other related lipids strongly inhibited the autophosphorylation of the EGFR kinase domain. This inhibitory action of GM3 was only seen in liposomes compositionally poised to phase separate into coexisting liquid domains. The inhibition by GM3 was released by either removing the neuraminic acid of the GM3 headgroup or by mutating a membrane proximal lysine of EGFR (K642G). Our results demonstrate that GM3 exhibits the potential to regulate the allosteric structural transition from inactive to a signaling EGFR dimer, by preventing the autophosphorylation of the intracellular kinase domain in response to ligand binding.

[1]  Christer S. Ejsing,et al.  Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry , 2009, Proceedings of the National Academy of Sciences.

[2]  Linda J Pike,et al.  Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system , 2008, Proceedings of the National Academy of Sciences.

[3]  S. Hakomori,et al.  GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. , 1994, The Journal of biological chemistry.

[4]  L. Pike,et al.  The Intracellular Juxtamembrane Domain of the Epidermal Growth Factor (EGF) Receptor Is Responsible for the Allosteric Regulation of EGF Binding*♦ , 2009, Journal of Biological Chemistry.

[5]  H. Simon,et al.  Interaction of the Extracellular Domain of the Epidermal Growth Factor Receptor with Gangliosides* , 2002, The Journal of Biological Chemistry.

[6]  P. Schwille,et al.  Lipids as Modulators of Proteolytic Activity of BACE , 2005, Journal of Biological Chemistry.

[7]  J. Schlessinger,et al.  Signaling by Receptor Tyrosine Kinases , 1993 .

[8]  Peter Klein,et al.  On the nature of low- and high-affinity EGF receptors on living cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Schlessinger Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[10]  Markus R Wenk,et al.  Lipidomics: New Tools and Applications , 2010, Cell.

[11]  J. M. Aerts,et al.  Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. , 2008, The Journal of clinical endocrinology and metabolism.

[12]  E. Elson,et al.  Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis. , 2007, Biophysical journal.

[13]  R. Proia,et al.  Enhanced insulin sensitivity in mice lacking ganglioside GM3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Ferguson,et al.  Structure-based view of epidermal growth factor receptor regulation. , 2008, Annual review of biophysics.

[15]  F. Studier,et al.  Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.

[16]  Jae-Hoon Kim,et al.  Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains , 2002, Cell.

[17]  D A Lauffenburger,et al.  Optimization of Cell Surface Binding Enhances Efficiency and Specificity of Molecular Conjugate Gene Delivery* , 1998, The Journal of Biological Chemistry.

[18]  S. Fleischer,et al.  Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots , 2007, Lipids.

[19]  S. Hakomori,et al.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. , 1988, The Journal of biological chemistry.

[20]  T. Hikita,et al.  Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor , 2006, Proceedings of the National Academy of Sciences.

[21]  P. Schwille,et al.  Combined AFM and two-focus SFCS study of raft-exhibiting model membranes. , 2006, Chemphyschem : a European journal of chemical physics and physical chemistry.

[22]  M. Lemmon,et al.  Ligand-induced structural transitions in ErbB receptor extracellular domains. , 2007, Structure.

[23]  Yosef Yarden,et al.  Feedback regulation of EGFR signalling: decision making by early and delayed loops , 2011, Nature Reviews Molecular Cell Biology.

[24]  T. Pawson,et al.  Cell Signaling in Space and Time: Where Proteins Come Together and When They’re Apart , 2009, Science.

[25]  J. Schlessinger,et al.  Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. , 1986, The Journal of biological chemistry.

[26]  J. Boonstra,et al.  Membrane vesicles of A431 cells contain one class of epidermal growth factor binding sites. , 1990, Biochimica et biophysica acta.

[27]  A. Pozzi,et al.  The juxtamembrane region of the EGF receptor functions as an activation domain. , 2009, Molecular cell.

[28]  E. Miljan,et al.  Regulation of Growth Factor Receptors by Gangliosides , 2002, Science's STKE.

[29]  R. Stevens,et al.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.

[30]  G. Todaro,et al.  Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors , 1979, Nature.

[31]  T. Jovin,et al.  Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis , 2010, Proceedings of the National Academy of Sciences.

[32]  Y. Igarashi,et al.  Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[33]  Stefan Raunser,et al.  Electron crystallography as a technique to study the structure on membrane proteins in a lipidic environment. , 2009, Annual review of biophysics.

[34]  A. Shevchenko,et al.  Lipidomics: coming to grips with lipid diversity , 2010, Nature Reviews Molecular Cell Biology.

[35]  Sagar A. Pandit,et al.  Lateral organization of complex lipid mixtures from multiscale modeling. , 2010, The Journal of chemical physics.

[36]  A. Paller,et al.  Ganglioside Induces Caveolin-1 Redistribution and Interaction with the Epidermal Growth Factor Receptor* , 2002, The Journal of Biological Chemistry.

[37]  J. Schlessinger,et al.  Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand-Induced Conformational Changes in the Dimer Interface , 2005, Molecular and Cellular Biology.

[38]  R. Schnaar,et al.  Gangliosides in cell recognition and membrane protein regulation. , 2009, Current opinion in structural biology.

[39]  Kai Simons,et al.  Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.

[40]  Y. Yarden,et al.  Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. , 1987, Biochemistry.

[41]  John Kuriyan,et al.  Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment , 2009, Cell.

[42]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[43]  G. Carpenter,et al.  Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation , 2007, Proceedings of the National Academy of Sciences.

[44]  L. Pike,et al.  Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. , 2002, Biochemistry.

[45]  Derek Toomre,et al.  Spatial control of EGF receptor activation by reversible dimerization on living cells , 2010, Nature.

[46]  M. Lemmon,et al.  Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor , 2010, Cell.